This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nolly, H. Articles by Scicli, A. G. Search for Related Content PubMed PubMed Citation Articles by Nolly, H. Articles by Scicli, A. G.

Hypertension, Vol 21, 911-915, Copyright © 1993 by American Heart Association

ARTICLES

Adrenal kallikrein

H Nolly, G Saed, OA Carretero, G Scicli and AG Scicli
Henry Ford Hospital, Hypertension and Vascular Research Division, Detroit, MI 48202.

Kallikrein was identified in the adrenal glands of the rat. The enzyme was present in active and inactive forms (n = 9), since preincubation with trypsin increased kininogenase activity from 54.8 +/- 11.8 to 230 +/- 23 pg bradykinin per milligram protein per minute. Adrenal kininogenase activity was inhibited by 91% by phenylmethylsulfonyl fluoride (2 mM), 81% by D-Phe-Phe-Arg-chloromethyl ketone (1 microM), 88% by aprotinin (1,000 KIU), and only 16% by soybean trypsin inhibitor (50 microM). Preincubation with antibodies against rat urinary kallikrein resulted in over 90% inhibition of kininogenase activity. Immunoreactive glandular kallikrein was 30.7 +/- 4.8 ng/mg protein (n = 11). The apparent molecular weight of the adrenal kininogenase on gel filtration chromatography was 33,000 +/- 500 D. Both the adrenal enzyme and the purified submandibular gland kallikrein used as a control had the same mobility on alkaline polyacrylamide gel electrophoresis. To determine whether messenger RNA (mRNA) for glandular kallikrein is present in adrenal gland RNA, we used the polymerase chain reaction employing oligonucleotide primers and glandular kallikrein 32P complementary DNA (cDNA) as a probe, which should give a cDNA fragment of 370 bp. Southern blots of the amplified products revealed a fragment of the predicted size. In conclusion, glandular kallikrein has been identified in the adrenal glands. The presence of mRNA for glandular kallikrein suggests that kallikrein is synthesized locally in this tissue. This provides an anatomic basis for possible participation of a local kallikrein-kinin pathway in the regulation of adrenal function.

This article has been cited by other articles:

				R. Forteza, I. Lauredo, W. M. Abraham, and G. E. Conner Bronchial Tissue Kallikrein Activity Is Regulated by Hyaluronic Acid Binding Am. J. Respir. Cell Mol. Biol., December 1, 1999; 21(6): 666 - 674. [Abstract] [Full Text]

				R. J. MacDonald, E. M. Southard-Smith, and E. Kroon Disparate Tissue-specific Expression of Members of the Tissue Kallikrein Multigene Family of the Rat J. Biol. Chem., June 7, 1996; 271(23): 13684 - 13690. [Abstract] [Full Text] [PDF]